• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

EBioMedicine . Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model

tetano

Editor, Senior Moderator
EBioMedicine


. 2022 Apr 16;79:103999.
doi: 10.1016/j.ebiom.2022.103999. Online ahead of print.
Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model


Christopher Käufer[SUP] 1 [/SUP], Cara S Schreiber[SUP] 2 [/SUP], Anna-Sophia Hartke[SUP] 2 [/SUP], Ivo Denden[SUP] 1 [/SUP], Stephanie Stanelle-Bertram[SUP] 3 [/SUP], Sebastian Beck[SUP] 3 [/SUP], Nancy Mounogou Kouassi[SUP] 3 [/SUP], Georg Beythien[SUP] 4 [/SUP], Kathrin Becker[SUP] 4 [/SUP], Tom Schreiner[SUP] 4 [/SUP], Berfin Schaumburg[SUP] 3 [/SUP], Andreas Beineke[SUP] 5 [/SUP], Wolfgang Baumgärtner[SUP] 5 [/SUP], Gülsah Gabriel[SUP] 6 [/SUP], Franziska Richter[SUP] 7 [/SUP]



Affiliations

Abstract

Background: Neurological symptoms such as cognitive decline and depression contribute substantially to post-COVID-19 syndrome, defined as lasting symptoms several weeks after initial SARS-CoV-2 infection. The pathogenesis is still elusive, which hampers appropriate treatment. Neuroinflammatory responses and neurodegenerative processes may occur in absence of overt neuroinvasion.
Methods: Here we determined whether intranasal SARS-CoV-2 infection in male and female syrian golden hamsters results in persistent brain pathology. Brains 3 (symptomatic) or 14 days (viral clearance) post infection versus mock (n = 10 each) were immunohistochemically analyzed for viral protein, neuroinflammatory response and accumulation of tau, hyperphosphorylated tau and alpha-synuclein protein.
Findings: Viral protein in the nasal cavity led to pronounced microglia activation in the olfactory bulb beyond viral clearance. Cortical but not hippocampal neurons accumulated hyperphosphorylated tau and alpha-synuclein, in the absence of overt inflammation and neurodegeneration. Importantly, not all brain regions were affected, which is in line with selective vulnerability.
Interpretation: Thus, despite the absence of virus in brain, neurons develop signatures of proteinopathies that may contribute to progressive neuronal dysfunction. Further in depth analysis of this important mechanism is required.
Funding: Federal Ministry of Health (BMG; ZMV I 1-2520COR501), Federal Ministry of Education and Research (BMBF 01KI1723G), Ministry of Science and Culture of Lower Saxony in Germany (14 - 76103-184 CORONA-15/20), German Research Foundation (DFG; 398066876/GRK 2485/1), Luxemburgish National Research Fund (FNR, Project Reference: 15686728, EU SC1-PHE-CORONAVIRUS-2020 MANCO, no > 101003651).

Keywords: Alpha-synuclein; Animal model; Neurodegenerative disease; Neuroinfection; Tau.
 
Back
Top Bottom